logo
LIFE-SUPPORTING HUMAN COMPLEMENT REGULATOR DECAY ACCELERATING FACTOR TRANSGENIC PIG LIVER XENOGRAFT MAINTAINS THE METABOLIC FUNCTION AND COAGULATION IN THE NONHUMAN PRIMATE FOR UP TO 8 DAYS1
MATRIX METALLOPROTEINASES CORRELATE WITH ALVEOLAR-CAPILLARY PERMEABILITY ALTERATION IN LUNG ISCHEMIA-REPERFUSION INJURY
DONOR T CELLS ARE NOT REQUIRED FOR INDUCTION OF ALLOGRAFT TOLERANCE IN MICE TREATED WITH ANTILYMPHOCYTE SERUM, RAPAMYCIN, AND DONOR BONE MARROW CELLS1
TRANSMISSION OF PORCINE ENDOGENOUS RETROVIRUSES IN SEVERE COMBINED IMMUNODEFICIENT MICE XENOTRANSPLANTED WITH FETAL PORCINE PANCREATIC CELLS1
MODULATION OF PULMONARY NA+ PUMP GENE EXPRESSION DURING COLD STORAGE AND REPERFUSION1
PHARMACOLOGIC GRAFT PROTECTION WITHOUT DONOR PRETREATMENT IN LIVER TRANSPLANTATION FROM NON-HEART-BEATING DONORS1
LEUKEMIA INHIBITORY FACTOR GENE IMPROVES SKIN ALLOGRAFT SURVIVAL IN THE MOUSE MODEL1
INFLUENCE OF DONOR AGE ON BOVINE PANCREATIC ISLET ISOLATION1
PHARMACODYNAMICS OF MYCOPHENOLIC ACID IN HEART ALLOGRAFT RECIPIENTS: CORRELATION OF LYMPHOCYTE PROLIFERATION AND ACTIVATION WITH PHARMACOKINETICS AND GRAFT HISTOLOGY1
PERIPHERAL VASCULAR OCCLUSIVE DISEASE IN RENAL TRANSPLANT RECIPIENTS: RISK FACTORS AND IMPACT ON KIDNEY ALLOGRAFT SURVIVAL
FLOW CYTOMETRIC DETECTION OF HLA-SPECIFIC ANTIBODIES AS A PREDICTOR OF HEART ALLOGRAFT REJECTION1
USE OF ALLOCHIMERIC PROTEINS TO MITIGATE GRAFT-VERSUS-HOST AND HOST-VERSUS-GRAFT IMMUNE RESPONSES TO RAT SMALL BOWEL ALLOGRAFTS1
A DIFFERENTIAL REQUIREMENT FOR CD8+ DONOR CELLS IN THE AUGMENTATION OF ALLOGRAFT SURVIVAL BY POSTTRANSPLANTATION ADMINISTRATION OF DONOR SPLEEN CELLS AND DONOR BONE MARROW CELLS1
CYTOKINE AND CYTOTOXIC MOLECULE GENE EXPRESSION DETERMINED IN PERIPHERAL BLOOD MONONUCLEAR CELLS IN THE DIAGNOSIS OF ACUTE RENAL REJECTION
CADAVERIC RENAL ALLOGRAFT AT THE TIME OF IMPLANTATION HAS THE SIMILAR IMMUNOLOGICAL FEATURES WITH THE REJECTING ALLOGRAFT1
IgG 2 ANTI-GALα1–3GAL DOES NOT INDUCE PORCINE AORTIC ENDOTHELIAL CELL ACCOMMODATION IN VITRO
HYDROPHOBIC EXTRACTS OF A CHINESE HERB (CMX-13) EXHIBIT POTENT IMMUNOSUPPRESSIVE PROPERTIES AND PREVENT ACUTE REJECTION IN A HIGHLY HISTOINCOMPATIBLE MODEL OF RAT LUNG TRANSPLANTATION1
INCREASED IMPACT OF ACUTE REJECTION ON CHRONIC ALLOGRAFT FAILURE IN RECENT ERA
AMPLIFICATION OF IMMUNOLOGICAL FUNCTIONS BY SUBCUTANEOUS INJECTION OF INTERMEDIATE-HIGH DOSE INTERLEUKIN-2 FOR 2 YEARS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION IN CHILDREN WITH STAGE IV NEUROBLASTOMA
RAPAMYCIN INDUCES TRANSFORMING GROWTH FACTOR-β PRODUCTION BY LYMPHOCYTES1
INCREASED NUCLEAR FACTOR-κB AND ANGIOTENSINOGEN GENE EXPRESSION IN POSTTRANSPLANT RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS1
CONTINUOUS LAMIVUDINE TREATMENT IN AN OLT PATIENT DESPITE THE APPEARANCE OF HBV RESISTANT STRAIN: LONGITUDINAL ANALYSIS
XENOTRANSPLANTATION AND THE COUNCIL OF EUROPE
Response to “A Novel United Network for Organ Sharing Region Kidney Allocation Plan Improves Transplant Access for Minority Candidates”
Response to “A Novel United Network for Organ Sharing Region Kidney Allocation Plan Improves Transplant Access for Minority Candidates”
STANDARDS FOR ECONOMIC AND QUALITY OF LIFE STUDIES IN TRANSPLANTATION
ESTIMATING THE BENEFITS OF SOLITARY PANCREAS TRANSPLANTATION IN NONUREMIC PATIENTS WITH TYPE 1 DIABETES MELLITUS: A THEORETICAL ANALYSIS
ANNOUNCEMENTS